Browse EX-10 agreements

Exhibit 10.4

**  **

ADMINISTRATION AGREEMENT

** **

between

BRIDGECREST LENDING AUTO SECURITIZATION TRUST 2026-4,

as Issuer,

BRIDGECREST LENDING AUTO SECURITIZATION GRANTOR TRUST 2026-4,

as Grantor Trust,

BRIDGECREST ACCEPTANCE CORPORATION,

as Administrator

and

COMPUTERSHARE TRUST COMPANY, NATIONAL ASSOCIATION,
as Indenture Trustee

Dated as of October 22, 2026

** **

** **

Table of Contents

** **

---

…

Exhibit 10.2

SALE AND SERVICING AGREEMENT

by and between

BRIDGECREST LENDING AUTO SECURITIZATION TRUST 2026-4,
as Issuer

BRIDGECREST LENDING AUTO SECURITIZATION GRANTOR TRUST 2026-4,
as Grantor Trust

BRIDGECREST AUTO FUNDING LLC,
as Seller

BRIDGECREST ACCEPTANCE CORPORATION,
as Servicer

COMPUTERSHARE TRUST COMPANY, NATIONAL ASSOCIATION,
as Standby Servicer

and

COMPUTERSHARE TRUST COMPANY, NATIONAL ASSOCIATION,
as Indenture Trustee

Dated as of October 22, 2026

Table of Contents

…

Exhibit 10.5

BRIDGECREST LENDING AUTO SECURITIZATION TRUST 2026-4

AMENDED AND RESTATED
TRUST AGREEMENT

between

BRIDGECREST AUTO FUNDING LLC,
as the Depositor

and

WILMINGTON TRUST, NATIONAL ASSOCIATION,
as the Owner Trustee

Dated as of October 22, 2026

Table of Contents

Page

ARTICLE I DEFINITIONS	1
SECTION 1.1. Capitalized Terms	1
SECTION 1.2. Other Interpretive Provisions	1

…

Exhibit 10.1

PURCHASE AGREEMENT

dated as of October 22, 2026

between

**BRIDGECREST ACCEPTANCE CORPORATION,
**as Seller

and

**BRIDGECREST AUTO FUNDING LLC, **

as Purchaser

Table of Contents

		Page
ARTICLE I	DEFINITIONS AND USAGE	1
SECTION 1.1 Definitions		1

…

Exhibit 10.7

** **

ASSET REPRESENTATIONS REVIEW AGREEMENT

Bridgecrest Lending Auto Securitization Trust 2026-4,
as Issuer,

Bridgecrest Lending Auto Securitization Grantor Trust 2026-4,
as Grantor Trust,

Bridgecrest Acceptance Corporation,
as Sponsor and Servicer

and

CLAYTON FIXED INCOME SERVICES LLC,
as Asset Representations Reviewer

Dated as of October 22, 2026

Table of Contents

Page

…

** **

CONSENT, WAIVER AND RATIFICATION OF HOLDERS OF SERIES D

CONVERTIBLE PREFERRED STOCK OF BOXLIGHT CORPORATION

Effective as of September 30, 2026

This CONSENT, WAIVER AND RATIFICATION (this “Consent”) is entered into by the undersigned holders of Series D Convertible Preferred Stock of Boxlight Corporation.

** **

RECITALS

A. Boxlight Corporation, a Nevada corporation (the “Company”), issued its Series D Convertible Preferred Stock (the “Series D Preferred”) under a Securities Purchase Agreement dated August 5, 2026 (the “Series D SPA”), a Certificate of Designation of the Series D Preferred (the “Series D Certificate”), and a Registration Rights Agreement dated August 5, 2026 (the “Series D RRA” and, together with the Series D SPA and Series D Certificate, the “Series D Documents”).

…

---

---

---

---

** **

AMENDMENT NO. 2

** **

TO

** **

SECURITIES PURCHASE AGREEMENT

This AMENDMENT NO. 2 TO SECURITIES PURCHASE AGREEMENT (this “Amendment”), dated as of October 7, 2026, is entered into between Axonex AI Group Limited (formerly known as Mint Incorporation Limited), a business company incorporated under the laws of the British Virgin Islands (the “Company”), and the undersigned Buyer.

RECITALS

** **

WHEREAS, the Company (then named Mint Incorporation Limited) and the Buyer are parties to (i) that certain Securities Purchase Agreement dated as of July 2, 2026 (the “July 2 Agreement”), pursuant to which the Company issued and sold Class A ordinary shares of no par value of the Company to the Buyer on July 8, 2026, and (ii) that certain Securities Purchase Agreement dated as of July 30, 2026 (the “July 30 Agreement” and, together with the July 2 Agreement, the “Original Agreements”), pursuant to which the Company issued and sold Class A ordinary shares of no par value of the Company to the Buyer on August 11, 2026;

** **

…

TENDER OFFER AGREEMENT

[Cavitation Technologies, Inc.]

** **

This TENDER OFFER AGREEMENT (“Agreement”), dated and made effective as of October 9, 2026 (“Effective Date”), is entered into by and between BRIGHTFLIXX FINANCE (LUXEMBOURG) S.A,, a public limited company (société anonyme) organized and existing under the laws of Luxembourg (“Purchaser”), and CAVITATION TECHNOLOGIES, INC., a corporation organized and existing under the laws of the State of Nevada (USA) (“Company”). The parties hereto are sometimes referred to individually herein as a “Party” or and collectively as the “Parties”.

R E C I T A L S

** **

A.Purchaser has proposed to acquire all of the outstanding shares of common stock in Company (the “Shares”), a reporting company under Section 13 and Section 15(d) of the Securities Exchange Act of 1934 (“Exchange Act”), for a total amount or price of $35 million in cash, less its outstanding liabilities, yielding a price per Share (“Offer Price”) determined in accordance with the terms of this Agreement) (the “Offer”);

…

SHARE REPURCHASE AND VOTING AGREEMENT

This Share Repurchase and Voting Agreement (this “Agreement”) is entered into as of October 13, 2026, by and among Alaunos Therapeutics, Inc., a Delaware corporation (“Parent”), Water Mill Asset Management Corp., a New York corporation (“Water Mill”), Robert W. Postma (“Postma” and, together with Water Mill, the “Postma Holders”), Jaime W. Vieser (“Vieser”) and, solely for purposes of Section 4(d), Velaris Therapeutics, Inc., a Delaware corporation (“Velaris”). Each of (a) the Postma Holders, together, and (b) Vieser is a “Holder”; each of Water Mill, Postma and Vieser is a “Holder Party”; and Postma and Vieser are each the “Holder Director” of his respective Holder.

…

Confidential

Proposed Execution Version

SECURITIES PURCHASE AGREEMENT

This SECURITIES PURCHASE AGREEMENT(this “Agreement”) is dated as of October 13, 2026, by and among Alaunos Therapeutics, Inc., a Delaware corporation (the “Company”), and each of the Persons listed on Exhibit A attached to this Agreement (each, an “Investor” and together, the “Investors”).

WHEREAS, the Company and the Investors are executing and delivering this Agreement in reliance upon the exemption from securities registration afforded by Section 4(a)(2) of the U.S. Securities Act of 1933, as amended (the “Securities Act”);

…

Confidential

Proposed Execution Version

REGISTRATION RIGHTS AGREEMENT

THIS REGISTRATION RIGHTS AGREEMENT(this “Agreement”), dated as of October 14, 2026, is entered into by and among Alaunos Therapeutics, Inc., a Delaware corporation (“Alaunos”), the several investors signatory hereto and each Merger Holder that becomes a party hereto in accordance with Section 10(b) (individually as an “Investor” and collectively, together with their respective permitted assigns, the “Investors”). Capitalized terms used herein and not otherwise defined herein shall have the respective meanings set forth in the Securities Purchase Agreement by and among Alaunos and the Investors party thereto, dated on or around the date hereof (as amended, restated, supplemented or otherwise modified from time to time, the “Purchase Agreement”).

WHEREAS:

…